Cherylann Pinto's Insider Trades & SAST Disclosures
Cherylann Pinto's most recent trade in Glenmark Pharmaceuticals Ltd. was a Acquisition of 1,950 Equity Shares done at an average price of Rs. 512.9 . Disclosure was reported to the exchange on Sept. 23, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Cherylann Pinto in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharma | CHERYLANN PINTO | Promoter | Acquisition | 23 Sep 2021 | 1,950 | 758,485 (0.27%) | 0.00% | 512.9 | 1,000,087 | 22 Sep 2021 22 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.